Dr. Anna Belman, MD

Dr. Belman practices at Stamford Hospital in Stamford, Connecticut.

Dr. Belman's NPI, 1699006221, was assigned on January 21, 2010. Dr. Belman holds Connecticut license 64872.

Dr. Belman's primary practice is Stamford Hospital, at 1 Hospital Plz, Stamford, CT 06902 in Western Ct County. The practice phone is (203) 276-1000.

Dr. Belman's primary practice is Stamford Hospital in Stamford, Connecticut. Dr. Belman is also affiliated with Stamford Hospital. The medical group on file is Westchester Medical Center Advanced Physician Services. Dmand AI also links Dr. Belman to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Belman practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Belman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Belman is licensed in Connecticut.

CMS data shows 59 Medicare services from Dr. Belman across 1 procedure code in 2024, for 64 Medicare patients. Medicare paid $8,090 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 64 Medicare patients who saw Dr. Belman in 2024. The largest group is 75 to 84, with 26 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Belman's median patient age at 65, with 56% women.

In 2024, Dr. Belman wrote 71 Medicare Part D claims for 24 patients. 93% of them were for generic drugs. CMS names the drug for 51 of them, across 2 drugs with 11 or more claims each, at $6,606 in total drug cost. In 2019, CMS named 12 claims across 1 drug.

Dr. Belman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Dr. Belman from 7 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $213.